环环库尔库强烈抑制人类芳酶作为潜在的治疗剂
Han Lu1, Jingyi Zheng2, Chunnan Hu2
1Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Key Laboratory of Anesthesiology of Zhejiang Province, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Key Laboratory of Environment and Male Reproductive Medicine of Wenzhou, Wenzhou Medical University, Zhejiang Province, China.
库尔库米诺酸有效抑制芳香酶 (CYP19A1),一种对雌激醇合成和乳腺癌扩散至关重要的酶. 这项研究突出了库尔库米诺类药物.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 库尔库米诺类药物,包括黄素,是已知的芳酶抑制剂 (CYP19A1).
- 芳酶对于雌激素合成至关重要,这是雌激素依赖性乳腺癌的关键因素.
- 了解氨酸抑制机制可以导致新的乳腺癌治疗方法.
研究的目的:
- 评估10种库尔库米诺类药物及其代谢物对人类和老鼠芳酶 (CYP19A1) 的疗效.
- 阐明这些化合物的抑制机制.
- 探索结构-活性关系,调节由类药物抑制芳酶的作用.
主要方法:
- 使用人类和老鼠胎盘显微体进行酶抑制测定,以确定IC50值.
- 使用人类BeWo细胞进行体外研究,以评估对雌激素产生的影响.
- 分子对接和3D-QSAR分析,以调查结合相互作用和预测抑制潜力.
主要成果:
- 对于测试的米类动物,观察到特定物种的IC50值.
- 环球黄素和黄素对人类和大鼠CYP19A1分别表现出强烈的抑制作用.
- 库尔库米诺类药物作为混合或竞争性抑制剂,降低BeWo细胞中的雌激素水平.
- 对接揭示了与CYP19A1活性部位的相互作用,包括与Met374.4的键.
- 3D-QSAR突出了结的意义,并确定了pKa,结合能量和抑制功率之间的相关性.
结论:
- 库尔库米诺类药物通过抑制芳酶,显示出作为乳腺癌治疗剂的显著潜力.
- 这项研究提供了对结构-活性关系和库尔库米诺伊德介导的芳酶抑制背后的分子机制的见解.
- 对特定的库尔库米诺类药物的进一步研究可能会导致开发新的抗乳腺癌药物.
更多相关视频
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
相关概念视频
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
Positive Regulator Molecules
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Internal Receptors
